There is no excerpt because this is a protected post. The post Netupitant/palonosetron in the Effective Management of Multiday Chemotherapy-induced Nausea and Vomiting appeared first on Medical News Asia | Powered by ['mediPr ..read more

Lung cancer continues to be a leading cause of cancer-related deaths in Hong Kong, with non-small cell lung cancer (NSCLC) accounting for about 82% of cases in 2021. Recent findings from the World Conference on Lung Cancer (WCLC) 2024, highlight promising advancements in the treatment of advanced NSCLC (aNSCLC). The post Advancements in aNSCLC Treatment: Highlights from WCLC 2024 appeared first on Medical News Asia | Powered by ['mediPr ..read more

Cervical cancer (CC) is the 4th most common cancer in women worldwide, with approximately 660,000 new cases in 2022. In Hong Kong, it was the 7th most common cancer among women in 2021, with approximately 600 new cases and 178 deaths. Here we report new findings on CC treatment and prognostic methods from three abstracts published at the annual ESMO Gynaecological Cancer Congress, 20–22 June 2024, Florence, Italy. The post Cervical Cancer Treatment and Prognosis: Revelations from ESMO 2024 Gynaecological Cancers Congress appeared first on Medical News Asia | Powered by ['mediPr ..read more

There is no excerpt because this is a protected post. The post Netupitant/palonosetron in the management of concurrent chemoradiotherapy-induced nausea and vomiting in head and neck cancer patient appeared first on Medical News Asia | Powered by ['mediPr ..read more

Ovarian cancer is the 8th most common cancer in women globally, with an age-standardised incidence rate of 6.7 per 100,000 in 2022. The post Advancements in Ovarian Cancer Treatment: Insights from ASCO 2024 appeared first on Medical News Asia | Powered by ['mediPr ..read more

Despite advances in treatment, nasopharyngeal carcinoma (NPC) remains a significant health burden. Recent trials presented by ASCO 2024 explore the new treatment alternatives and efficacy of therapies. The post Advancements in Nasopharyngeal Carcinoma Treatment: Insights from ASCO 2024 appeared first on Medical News Asia | Powered by ['mediPr ..read more

Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer characterised by the absence of oestrogen receptors (ER), progesterone receptors, and human epidermal growth factor receptor 2 (HER2) amplification.1,2 Representing about 10–15% of all breast cancer cases, TNBC is associated with poor prognosis and limited treatment options.2 Recent research findings presented at the 2024 American Society of Clinical Oncology (ASCO) meeting provided updates on new advances in the treatment of TNBC. The post Redefining HERness: HER2-low and ultralow breast cancers appeared firs ..read more

There is no excerpt because this is a protected post. The post NEPA as an Effective Therapeutic Approach for Managing ADC-Induced Nausea and Vomiting appeared first on Medical News Asia | Powered by ['mediPr ..read more

Lung cancer remains a leading cause of cancer-related deaths worldwide. Advances in targeted therapies improving the outcome for lung cancer patients were highlighted at the ASCO 2024 conference. A summary of clinical data, focusing on novel treatment options and new combination-therapies. The post Advancements in Lung Cancer Treatment: Insights from ASCO 2024 appeared first on Medical News Asia | Powered by ['mediPr ..read more

Hepatocellular carcinoma (HCC), is a devastating disease with limited treatment options. Recent trials presented by ASCO 2024 spotlight new findings on neoadjuvant immunotherapy, combination regimens for HCC, and efficacy of novel monotherapies. The post Advancements in Hepatocellular Carcinoma Treatment: Insights from ASCO 2024 appeared first on Medical News Asia | Powered by ['mediPr ..read more